dlid,source,drug_label,prescribing_guideline,dosing_guideline,chemical,gene,hap_var
PA166271261,EMA,2,1,-1,tegafur / gimeracil / oteracil,DPYD,"DPYD c.1129-5923C>G, c.1236G>A (HapB3); DPYD c.1679T>G (*13); DPYD c.1905+1G>A (*2A); DPYD c.2846A>T"
PA166273501,EMA,4,-1,-1,ipilimumab,CTLA4,HLA-A*02:01
PA166273501,EMA,4,-1,-1,ipilimumab,HLA-A,HLA-A*02:01
PA166272581,HCSC,1,1,-1,sotorasib,KRAS,rs121913530
PA166272601,EMA,1,1,-1,sotorasib,KRAS,rs121913530
PA166271541,EMA,3,1,-1,sacituzumab govitecan-hziy,UGT1A1,UGT1A1*28
PA166272721,EMA,1,1,-1,risdiplam,SMN1,
PA166184116,Swissmedic,1,1,-1,carbamazepine,HLA-B,HLA-B*15:02:01
PA166184506,Swissmedic,1,1,-1,dolutegravir / abacavir / lamivudine,HLA-B,HLA-B*57:01
PA166184442,Swissmedic,3,-1,-1,duloxetine,CYP2D6,
PA166184449,Swissmedic,2,-1,-1,flucytosine,DPYD,
PA166183786,Swissmedic,3,-1,-1,amlodipine / atorvastatin / perindopril arginine,G6PD,rs4149056
PA166183786,Swissmedic,3,-1,-1,amlodipine / atorvastatin / perindopril arginine,SLCO1B1,rs4149056
PA166271561,HCSC,3,1,-1,sacituzumab govitecan-hziy,UGT1A1,UGT1A1*28
PA166272741,EMA,4,-1,-1,ropeginterferon alfa-2b,JAK2,rs77375493
PA166182280,FDA,1,1,-1,dacomitinib,EGFR,rs121434568
PA166272821,EMA,1,1,1,siponimod,CYP2C9,CYP2C9*1; CYP2C9*11; CYP2C9*2; CYP2C9*3; CYP2C9*5; CYP2C9*6; CYP2C9*8
PA166268882,FDA,3,1,-1,belzutifan,CYP2C19,CYP2C19*2; CYP2C19*3
PA166268882,FDA,3,1,-1,belzutifan,UGT2B17,CYP2C19*2; CYP2C19*3
PA166104860,FDA,3,1,-1,phenytoin,CYP2C19,CYP2C9*2; CYP2C9*3; HLA-B*15:02:01
PA166104860,FDA,3,1,-1,phenytoin,CYP2C9,CYP2C9*2; CYP2C9*3; HLA-B*15:02:01
PA166104860,FDA,3,1,-1,phenytoin,HLA-B,CYP2C9*2; CYP2C9*3; HLA-B*15:02:01
PA166284241,HCSC,3,1,-1,fosphenytoin,HLA-B,HLA-B*15:02:01
PA166284661,HCSC,4,-1,-1,pembrolizumab,BRAF,rs113488022
